DRTS
Price
$2.64
Change
-$0.03 (-1.12%)
Updated
Apr 24, 04:14 PM (EDT)
Capitalization
185.8M
26 days until earnings call
SAGE
Price
$7.79
Change
+$0.17 (+2.23%)
Updated
Apr 24 closing price
Capitalization
478.94M
4 days until earnings call
Ad is loading...

DRTS vs SAGE

Header iconDRTS vs SAGE Comparison
Open Charts DRTS vs SAGEBanner chart's image
Alpha Tau Medical
Price$2.64
Change-$0.03 (-1.12%)
Volume$1K
Capitalization185.8M
Sage Therapeutics
Price$7.79
Change+$0.17 (+2.23%)
Volume$814.16K
Capitalization478.94M
DRTS vs SAGE Comparison Chart
Loading...
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRTS vs. SAGE commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRTS is a StrongBuy and SAGE is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (DRTS: $2.64 vs. SAGE: $7.79)
Brand notoriety: DRTS and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRTS: 39% vs. SAGE: 63%
Market capitalization -- DRTS: $185.8M vs. SAGE: $478.94M
DRTS [@Biotechnology] is valued at $185.8M. SAGE’s [@Biotechnology] market capitalization is $478.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRTS’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 0 green FA rating(s).

  • DRTS’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 0 green, 5 red.
According to our system of comparison, both DRTS and SAGE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRTS’s TA Score shows that 2 TA indicator(s) are bullish while SAGE’s TA Score has 7 bullish TA indicator(s).

  • DRTS’s TA Score: 2 bullish, 4 bearish.
  • SAGE’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, SAGE is a better buy in the short-term than DRTS.

Price Growth

DRTS (@Biotechnology) experienced а +2.72% price change this week, while SAGE (@Biotechnology) price change was +4.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

DRTS is expected to report earnings on Aug 21, 2025.

SAGE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SAGE($479M) has a higher market cap than DRTS($186M). SAGE YTD gains are higher at: 43.462 vs. DRTS (-13.871). DRTS has higher annual earnings (EBITDA): -30.34M vs. SAGE (-409.48M). SAGE has more cash in the bank: 504M vs. DRTS (59.6M). SAGE has less debt than DRTS: SAGE (11.8M) vs DRTS (12.5M). SAGE has higher revenues than DRTS: SAGE (41.2M) vs DRTS (0).
DRTSSAGEDRTS / SAGE
Capitalization186M479M39%
EBITDA-30.34M-409.48M7%
Gain YTD-13.87143.462-32%
P/E RatioN/AN/A-
Revenue041.2M-
Total Cash59.6M504M12%
Total Debt12.5M11.8M106%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DRTSSAGE
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 9 days ago
73%
Bearish Trend 17 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Ad is loading...
DRTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SGQCX37.51N/A
N/A
DWS International Growth C
HIMDX20.09N/A
N/A
Hennessy Cornerstone Mid Cap 30 Instl
GSMVX14.49N/A
N/A
Goldman Sachs Small/Mid Cap Value Instl
ISTNX61.33N/A
N/A
Macquarie Science and Technology R6
CMIRX7.25N/A
N/A
Conestoga Discovery Institutional

DRTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRTS has been loosely correlated with ARDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DRTS jumps, then ARDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRTS
1D Price
Change %
DRTS100%
+1.91%
ARDX - DRTS
34%
Loosely correlated
+0.52%
SAGE - DRTS
28%
Poorly correlated
-0.78%
HOOK - DRTS
24%
Poorly correlated
+4.00%
COGT - DRTS
24%
Poorly correlated
+3.00%
XOMA - DRTS
24%
Poorly correlated
+0.82%
More